The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis

BACKGROUND: Biologic disease-modifying antirheumatic drugs (bDMARDs) are important options for managing rheumatoid arthritis (RA). Once patients achieve disease control, clinicians may consider dose reduction or withdrawal of the bDMARD. Results from published studies indicate that some patients wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshiya, Smolen, Josef S., Jones, Heather, Szumski, Annette, Marshall, Lisa, Emery, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610967/
https://www.ncbi.nlm.nih.gov/pubmed/31277720
http://dx.doi.org/10.1186/s13075-019-1937-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610967/
https://www.ncbi.nlm.nih.gov/pubmed/31277720
http://dx.doi.org/10.1186/s13075-019-1937-4

Ejemplares similares